New Psychopharmacologic Treatment Strategies
Authors: Peter E. Stokes
Journal: Annals of Internal Medicine (2001)

Letters4 December 2001New Psychopharmacologic Treatment StrategiesPeter E. Stokes, MDPeter E. Stokes, MDNew York Presbyterian Hospital–Weill Medical College of Cornell University; White Plains, NY 10605Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-135-11-200112040-00021 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The article by Glick and associates (1) on psychopharmacologic treatment of depression, bipolar disorders, and schizophrenia is in my estimation a nice overview for nonpsychiatrist physicians. My own interest and long experience in teaching physicians outside psychiatry about depression and related disorders made this a particularly appealing article to me as a psychiatrist and internist. The authors appropriately emphasize the use of psychiatric consultation for patients with severe, diagnostically unclear, unresponsive, or otherwise undifferentiated cases, and I would add perhaps cases that suggest bipolar disease. Simultaneously, the authors underscore that patients with less severe disease and without ...References1. Glick ID, Suppes T, DeBattista C, Hu RJ, Marder S. Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia. Ann Intern Med. 2001;134:47-60. [PMID: 11187420] LinkGoogle Scholar2. Stokes PE, Shamoian CA, Stoll PM, Patton MJ. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet. 1971;1:1319-25. [PMID: 4103395] CrossrefMedlineGoogle Scholar3. Katz MM, Bowden C, Stokes P, Casper R, Frazer A, Koslow SH, et al . Can the effects of antidepressants be observed in the first two weeks of treatment? [Letter]. Neuropsychopharmacology. 1997;17:110-5. [PMID: 9252986] MedlineGoogle Scholar4. Katz MM, Koslow SH, Maas JW, Frazer A, Kocsis J, Secunda S, et al . Identifying the specific clinical actions of amitriptyline: interrelationships of behaviour, affect and plasma levels in depression. Psychol Med. 1991;21:599-611. [PMID: 1946849] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Peter E. Stokes, MDAffiliations: New York Presbyterian Hospital–Weill Medical College of Cornell University; White Plains, NY 10605 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoPsychopharmacologic Treatment Strategies for Depression, Bipolar Disorder, and Schizophrenia Ira D. Glick , Trisha Suppes , Charles DeBattista , Rona J. Hu , and Stephen Marder New Psychopharmacologic Treatment Strategies Ira D. Glick and Charles DeBattista Metrics 4 December 2001Volume 135, Issue 11Page: 1008KeywordsAdverse reactionsAnticonvulsantsAntidepressant drug therapyAntidepressantsBipolar disorderFood and Drug AdministrationPsychiatry and mental healthResearch laboratoriesSchizophreniaSelective serotonin reuptake inhibitors ePublished: 4 December 2001 Issue Published: 4 December 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...